{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~$1.89 vs. cons $1.84",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic operational revenue growth (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~+3.0% vs. cons ~+1.6%",
      "confidence": "LOW"
    },
    {
      "kpi": "U.S. companion-animal organic growth (Q2'26)",
      "prediction": "BEAT",
      "answer": "pred ~-3% vs. cons ~-4% (less-bad = stabilization)",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 adjusted diluted EPS guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~$6.85-7.00 held vs. cons ~$6.90 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 organic operational revenue growth guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~+2-5% held vs. cons ~+2% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 revenue guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~$9.68-9.96B held vs. cons ~$9.8B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 6.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 7.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Positioning is washed out after a ~41% YTD drawdown and shares have based near $74-77 for two months. A modest EPS beat (cost-program leverage + buybacks), held FY guidance rather than a third cut, and less-bad U.S. companion-animal/Librela exit rates confirm a trough narrative, triggering a relief rally and short-covering. Out-period math is the risk: the +2-5% FY guide still embeds a big 2H ramp, so if the beat is low quality (livestock/FYA-flattered) estimates could drift and the pop would fade \u2014 hence follow-through is modest and low-conviction, tilting toward stabilize.",
  "day5_confidence": "LOW"
}